New treatment approaches for multiple sclerosis are gaining attention, focusing on using exposure therapy to retrain the immune system. These innovative techniques aim to achieve multi-antigen tolerance, addressing the complexities of autoimmune responses. While some methods are still in early stages, one has successfully completed a safety trial and is moving towards efficacy trials, offering hope for a long-sought solution.
